-
1
-
-
37449005152
-
Autism spectrum disorders: Concurrent clinical disorders
-
Ming X., Brimacombe M., Chaaban J., et al. Autism spectrum disorders: concurrent clinical disorders. J Child Neurol. 2008 ; 23 (1). 6-13.
-
(2008)
J Child Neurol
, vol.23
, Issue.1
, pp. 6-13
-
-
Ming, X.1
Brimacombe, M.2
Chaaban, J.3
-
2
-
-
54049103639
-
Prevalence and risk factors of maladaptive behaviour in young children with autistic disorder
-
Hartley SL, Sikora DM, McCoy R. Prevalence and risk factors of maladaptive behaviour in young children with autistic disorder. J Intellect Disabil Res. 2008 ; 52 (10). 819-829.
-
(2008)
J Intellect Disabil Res
, vol.52
, Issue.10
, pp. 819-829
-
-
Hartley, S.L.1
Sikora, D.M.2
McCoy, R.3
-
3
-
-
37349022422
-
Level of intellectual functioning predicts patterns of associated symptoms in school-age children with autism spectrum disorder
-
DOI 10.1352/0895-8017(2007)112[439:LOIFPP]2.0.CO;2
-
Estes AM, Dawson G., Sterling L., Munson J. Level of intellectual functioning predicts patterns of associated symptoms in school-age children with autism spectrum disorder. Am J Ment Retard. 2007 ; 112 (6). 439-449. (Pubitemid 350305116)
-
(2007)
American Journal on Mental Retardation
, vol.112
, Issue.6
, pp. 439-449
-
-
Estes, A.M.1
Dawson, G.2
Sterling, L.3
Munson, J.4
-
4
-
-
0033917855
-
The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders
-
Posey DJ, McDougle CJ The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harv Rev Psychiatry. 2000 ; 8 (2). 45-63. (Pubitemid 30421511)
-
(2000)
Harvard Review of Psychiatry
, vol.8
, Issue.2
, pp. 45-63
-
-
Posey, D.J.1
McDougle, C.J.2
-
5
-
-
0030927811
-
Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study
-
DOI 10.1097/00004583-199706000-00022
-
Campbell M., Armenteros JL, Malone RP, et al. Neurolepticrelated dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry. 1997 ; 36 (6). 835-843. (Pubitemid 27250449)
-
(1997)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.36
, Issue.6
, pp. 835-843
-
-
Campbell, M.1
Armenteros, J.L.2
Malone, R.P.3
Adams, P.B.4
Eisenberg, Z.W.5
Overall, J.E.6
-
6
-
-
0002262786
-
Pharmacokinetics and safety of risperidone in autistic children
-
Casaer P., Walleghem D., Vandenbussche I., et al. Pharmacokinetics and safety of risperidone in autistic children. Pediatr Neurol. 1994 ; 11: 89.
-
(1994)
Pediatr Neurol
, vol.11
, pp. 89
-
-
Casaer, P.1
Walleghem, D.2
Vandenbussche, I.3
-
7
-
-
0030966387
-
An open clinical trial of risperidone monotherapy in young children with autistic disorder
-
Findling RL, Maxwell K., Wiznitzer M. An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol Bull. 1997 ; 33: 155-159. (Pubitemid 27184211)
-
(1997)
Psychopharmacology Bulletin
, vol.33
, Issue.1
, pp. 155-159
-
-
Findling, R.L.1
Maxwell, K.2
Wiznitzer, M.3
-
8
-
-
0030937715
-
Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study
-
McDougle CJ, Holmes JP, Bronson MR, et al. Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. J Am Acad Child Adolesc Psychiatry. 1997 ; 36: 685-693. (Pubitemid 27184077)
-
(1997)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.36
, Issue.5
, pp. 685-693
-
-
McDougle, C.J.1
Holmes, J.P.2
Bronson, M.R.3
Anderson, G.M.4
Volkmar, F.R.5
Price, L.H.6
Cohen, D.J.7
-
10
-
-
0033940555
-
Long-term risperidone for pervasive developmental disorder: Efficacy, tolerability, and discontinuation
-
Zuddas A., Di Martino A., Muglia P., Cianchetti C. Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation. J Am Acad Child Adolesc Psychiatry. 2000 ; 10: 79-90. (Pubitemid 30490915)
-
(2000)
Journal of Child and Adolescent Psychopharmacology
, vol.10
, Issue.2
, pp. 79-90
-
-
Zuddas, A.1
Di Martino, A.2
Muglia, P.3
Cianchetti, C.4
-
11
-
-
16644370679
-
Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders
-
Shea S., Turgay A., Carroll A., et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004 ; 114: e634 - e641.
-
(2004)
Pediatrics
, vol.114
-
-
Shea, S.1
Turgay, A.2
Carroll, A.3
-
12
-
-
0036682267
-
Risperidone in children with autism and serious behavioral problems
-
DOI 10.1056/NEJMoa013171
-
McCracken JT, McGough J., Shah B., et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002 ; 347: 314-321. (Pubitemid 34815353)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.5
, pp. 314-321
-
-
McCracken, J.T.1
McGough, J.2
Shah, B.3
Cronin, P.4
Hong, D.5
Aman, M.G.6
Eugene Arnold, L.7
Lindsay, R.8
Nash, P.9
Hollway, J.10
McDougle, C.J.11
Posey, D.12
Swiezy, N.13
Kohn, A.14
Scahill, L.15
Martin, A.16
Koenig, K.17
Volkmar, F.18
Carroll, D.19
Lancor, A.20
Tierney, E.21
Ghuman, J.22
Gonzalez, N.M.23
Grados, M.24
Vitiello, B.25
Ritz, L.26
Davies, M.27
Robinson, J.28
McMahon, D.29
more..
-
13
-
-
77951668684
-
Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability
-
Arnold LE, Farmer C., Kraemer HC, et al. Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol. 2010 ; 20 (2). 83-93.
-
(2010)
J Child Adolesc Psychopharmacol.
, vol.20
, Issue.2
, pp. 83-93
-
-
Arnold, L.E.1
Farmer, C.2
Kraemer, H.C.3
-
14
-
-
27144532065
-
Long-term effects of risperidone in children with autism spectrum disorders: A placebo discontinuation study
-
DOI 10.1097/01.chi.0000177055.11229.76
-
Troost PW, Lahuis BE, Steenhuis MP, et al. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. J Am Acad Child Adolesc Psychiatry. 2005 ; 44: 1137-1144. (Pubitemid 41508125)
-
(2005)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.44
, Issue.11
, pp. 1137-1144
-
-
Troost, P.W.1
Lahuis, B.E.2
Steenhuis, M.-P.3
Ketelaars, C.E.J.4
Buitelaar, J.K.5
Van Engeland, H.6
Scahill, L.7
Minderaa, R.B.8
Hoekstra, P.J.9
-
15
-
-
0036138792
-
A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders
-
DOI 10.1016/S0278-5846(01)00264-0, PII S0278584601002640
-
Simeon J., Milin R., Walker S. A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2002 ; 26: 267-275. (Pubitemid 34038053)
-
(2002)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
, vol.26
, Issue.2
, pp. 267-275
-
-
Simeon, J.1
Milin, R.2
Walker, S.3
-
16
-
-
12144285625
-
Outcome Measures for Clinical Drug Trials in Autism
-
Aman MG, Novotny S., Samango-Sprouse C., et al. Outcome measures for clinical drug trials in autism. CNS Spectr. 2004 ; 9: 36-47. (Pubitemid 38419005)
-
(2004)
CNS Spectrums
, vol.9
, Issue.1
, pp. 36-47
-
-
Aman, M.G.1
Novotny, S.2
Samango-Sprouse, C.3
Lecavalier, L.4
Leonard, E.5
Gadow, K.D.6
King, B.H.7
Pearson, D.A.8
Gernsbacher, M.A.9
Chez, M.10
|